about
Ethical aspects of malaria control and researchPlasmodium vivax Controlled Human Malaria Infection - Progress and ProspectsMalaria vaccine clinical trials: what's on the horizonTuberculosis vaccines: barriers and prospects on the quest for a transformative toolSafety and comparability of controlled human Plasmodium falciparum infection by mosquito bite in malaria-naïve subjects at a new facility for sporozoite challengeThe Malaria-High Blood Pressure Hypothesis.Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, KenyaVaccinology in the era of high-throughput biology.A review of clinical models for the evaluation of human TB vaccines.An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge Infections.Development of whole sporozoite malaria vaccines.Considerations for Comprehensive Analyses of Sporozoite-Based Controlled Human Malaria Infection Studies.malERA: An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication.malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication.Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection‡.Mosquito saliva: the hope for a universal arbovirus vaccine?Investigating zoonotic infection barriers to ape Plasmodium parasites using faecal DNA analysis.Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya.Transcriptomic Studies of Malaria: a Paradigm for Investigation of Systemic Host-Pathogen InteractionsWhole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period.Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoitesAdvanced model systems and tools for basic and translational human immunology
P2860
Q26773470-4FE8668C-7B12-4A6E-B847-4C6B2841361EQ28066456-E231CECD-0B7A-4C6C-8DE8-8DBBEE39B6FFQ28083110-A4707873-ED96-46E5-B7FA-1A3A45E95B74Q28390218-12AE3473-13F5-416D-9E0F-3ED0B36C6915Q28545017-C923CE59-DBC2-4B01-93E1-8888FEB66297Q30251413-F42D0436-81FD-488F-9F08-55B13E870201Q30403003-B9D078F6-9955-4BDB-96E7-9199587BC10EQ35559418-26295591-A149-4ADC-9DA4-26FA6089E8D8Q35923851-8EF83C53-E70E-4CA2-A967-5EB6C09E5799Q38711772-45375FD1-6001-48BA-B187-11CAD1ECC0A1Q38794455-F5E497F0-F781-4979-9C21-1ABC84163710Q38849181-AE73D268-AEF4-4CF5-A9E7-22075A56B4F8Q38872073-9F3B3FF4-045C-4438-86A4-3F8519646955Q38961574-7C0C195D-004E-4F49-A6AF-0D17652849FEQ47134819-4B463383-C5EF-479A-B701-47E4A599F668Q47162062-6798F5BB-2DC4-4157-AF67-8AB005E7317EQ50281824-D9771E44-8DDD-4466-ABE6-DFC48BC0352AQ52607156-F30655DE-17EC-4778-86C6-309D8D2CBAD0Q53702464-75F5A4A8-C4F8-4FDD-B2B4-6F00BCD97BC6Q55002323-BA06909D-7293-453E-9570-50529B28B659Q55106515-28C56818-AA0C-4345-8167-5D6D76657285Q55381231-297389B5-DF42-4DB7-A94B-31A439FF9551Q56345472-1C477CF9-2FE5-4927-A32B-58A8872E247EQ59126043-5DDAB27B-F429-42F8-A068-87BE3706FE13
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Controlled human malaria infection.
@en
type
label
Controlled human malaria infection.
@en
prefLabel
Controlled human malaria infection.
@en
P2093
P2860
P356
P1476
Controlled human malaria infection.
@en
P2093
Christian Ockenhouse
Mark Polhemus
Michele Spring
P2860
P356
10.1093/INFDIS/JIU063
P407
P478
209 Suppl 2
P577
2014-06-01T00:00:00Z